Literature DB >> 12376530

Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages.

Vidya V Kunjathoor1, Maria Febbraio, Eugene A Podrez, Kathryn J Moore, Lorna Andersson, Stephanie Koehn, Jeongmi S Rhee, Roy Silverstein, Henry F Hoff, Mason W Freeman.   

Abstract

Modification of low density lipoprotein (LDL) can result in the avid uptake of these lipoproteins via a family of macrophage transmembrane proteins referred to as scavenger receptors (SRs). The genetic inactivation of either of two SR family members, SR-A or CD36, has been shown previously to reduce oxidized LDL uptake in vitro and atherosclerotic lesions in mice. Several other SRs are reported to bind modified LDL, but their contribution to macrophage lipid accumulation is uncertain. We generated mice lacking both SR-A and CD36 to determine their combined impact on macrophage lipid uptake and to assess the contribution of other SRs to this process. We show that SR-A and CD36 account for 75-90% of degradation of LDL modified by acetylation or oxidation. Cholesteryl ester derived from modified lipoproteins fails to accumulate in macrophages taken from the double null mice, as assessed by histochemistry and gas chromatography-mass spectrometry. These results demonstrate that SR-A and CD36 are responsible for the preponderance of modified LDL uptake in macrophages and that other scavenger receptors do not compensate for their absence.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12376530     DOI: 10.1074/jbc.M209649200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  310 in total

1.  oxHDL decreases the expression of CD36 on human macrophages through PPARgamma and p38 MAP kinase dependent mechanisms.

Authors:  Jingyi Ren; Wenying Jin; Hong Chen
Journal:  Mol Cell Biochem       Date:  2010-05-11       Impact factor: 3.396

2.  How does interferon-α insult the vasculature? Let me count the ways.

Authors:  Mariana J Kaplan; Jane E Salmon
Journal:  Arthritis Rheum       Date:  2011-02

3.  Effect of oxidized low-density lipoprotein concentration polarization on human smooth muscle cells' proliferation, cycle, apoptosis and oxidized low-density lipoprotein uptake.

Authors:  Zufeng Ding; Shijie Liu; Bo Yang; Yubo Fan; Xiaoyan Deng
Journal:  J R Soc Interface       Date:  2011-11-02       Impact factor: 4.118

4.  Role of liver sinusoidal endothelial cells and stabilins in elimination of oxidized low-density lipoproteins.

Authors:  Ruomei Li; Ana Oteiza; Karen Kristine Sørensen; Peter McCourt; Randi Olsen; Bård Smedsrød; Dmitri Svistounov
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-10-28       Impact factor: 4.052

5.  The effect of 17β-estradiol on cholesterol content in human macrophages is influenced by the lipoprotein milieu.

Authors:  Michael P Corcoran; Alice H Lichtenstein; Mohsen Meydani; Alice Dillard; Ernst J Schaefer; Stefania Lamon-Fava
Journal:  J Mol Endocrinol       Date:  2011-08       Impact factor: 5.098

Review 6.  How dendritic cells shape atherosclerosis.

Authors:  Ekaterina K Koltsova; Klaus Ley
Journal:  Trends Immunol       Date:  2011-08-10       Impact factor: 16.687

Review 7.  The danger model: questioning an unconvincing theory.

Authors:  Szczepan Józefowski
Journal:  Immunol Cell Biol       Date:  2015-07-28       Impact factor: 5.126

Review 8.  From proliferation to proliferation: monocyte lineage comes full circle.

Authors:  Filip K Swirski; Ingo Hilgendorf; Clinton S Robbins
Journal:  Semin Immunopathol       Date:  2014-01-17       Impact factor: 9.623

Review 9.  Emerging roles of calpain proteolytic systems in macrophage cholesterol handling.

Authors:  Takuro Miyazaki; Akira Miyazaki
Journal:  Cell Mol Life Sci       Date:  2017-04-21       Impact factor: 9.261

10.  Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice.

Authors:  Kathryn J Moore; Vidya V Kunjathoor; Stephanie L Koehn; Jennifer J Manning; Anita A Tseng; Jessica M Silver; Mary McKee; Mason W Freeman
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.